This topic contains a solution. Click here to go to the answer

Author Question: This is a clause that informs the client that the attorney-client relationship is not established ... (Read 45 times)

bclement10

  • Hero Member
  • *****
  • Posts: 560
This is a clause that informs the client that the attorney-client relationship is not established until the client signs a retainer agreement and pays the attorney's fee.
 
  A) Notice of non-representation
  B) Notice of non-compliance
  C) Notice of limited representation
  D) Notice of intent not to represent

Question 2

The ________ is a document that lists all the mandatory disclosures required in Section 527,
 
  A) Retainer agreement
  B) Disclosure agreement
  C) Discovery and production agreement
  D) None of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

heyhey123

  • Sr. Member
  • ****
  • Posts: 353
Answer to Question 1

A

Answer to Question 2

B




bclement10

  • Member
  • Posts: 560
Reply 2 on: Aug 2, 2018
Excellent


  • Member
  • Posts:
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library